Selected research
Industry Research
Skin Patch Industry Research Report 2026
Market perspective
The global Skin Patch market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Skin Patch is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Skin Patch is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Skin Patch include GSK, Teva Pharmaceutical Industries, Sanofi, Johnson & Johnson, Novartis, Mylan, Lingrui, Bayer and Teikoku Seiyaku, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Skin Patch market in terms of revenue (US$ million) and, where applicable, sales volume (k pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Skin Patch Market by Company
GSK
Teva Pharmaceutical Industries
Sanofi
Johnson & Johnson
Novartis
Mylan
Lingrui
Bayer
Teikoku Seiyaku
Purdue Pharma
Mundipharma International
Luye Pharma Group
Hisamitsu Pharmaceutical
Skin Patch Segment by Type
Buprenorphine
Fentanyl
Clonidine
Nicotine
Skin Patch Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Skin Patch Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Skin Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Skin Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Skin Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Skin Patch manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Skin Patch by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Skin Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Buprenorphine
- Fentanyl
- Clonidine
- Nicotine
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- GSK
- Teva Pharmaceutical Industries
- Sanofi
- Johnson & Johnson
- Novartis
- Mylan
- Lingrui
- Bayer
- Teikoku Seiyaku
- Purdue Pharma
- Mundipharma International
- Luye Pharma Group
- Hisamitsu Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Skin Patch Market Size (2021-2032)
- 2.2.2 Global Skin Patch Sales (2021-2032)
- 2.2.3 Global Skin Patch Market Average Price (2021-2032)
- 2.3 Skin Patch by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Buprenorphine
- 2.3.3 Fentanyl
- 2.3.4 Clonidine
- 2.3.5 Nicotine
- 2.4 Skin Patch by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Skin Patch Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Skin Patch Sales (k pcs) of Manufacturers (2021-2026)
- 3.3 Global Skin Patch Revenue of Manufacturers (2021-2026)
- 3.4 Global Skin Patch Average Price by Manufacturers (2021-2026)
- 3.5 Global Skin Patch Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Skin Patch, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Skin Patch, Product Type & Application
- 3.8 Global Manufacturers of Skin Patch, Established Date
- 3.9 Global Skin Patch Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GSK
- 4.1.1 GSK Company Information
- 4.1.2 GSK Business Overview
- 4.1.3 GSK Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GSK Skin Patch Product Portfolio
- 4.1.5 GSK Recent Developments
- 4.2 Teva Pharmaceutical Industries
- 4.2.1 Teva Pharmaceutical Industries Company Information
- 4.2.2 Teva Pharmaceutical Industries Business Overview
- 4.2.3 Teva Pharmaceutical Industries Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Teva Pharmaceutical Industries Skin Patch Product Portfolio
- 4.2.5 Teva Pharmaceutical Industries Recent Developments
- 4.3 Sanofi
- 4.3.1 Sanofi Company Information
- 4.3.2 Sanofi Business Overview
- 4.3.3 Sanofi Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi Skin Patch Product Portfolio
- 4.3.5 Sanofi Recent Developments
- 4.4 Johnson & Johnson
- 4.4.1 Johnson & Johnson Company Information
- 4.4.2 Johnson & Johnson Business Overview
- 4.4.3 Johnson & Johnson Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Johnson & Johnson Skin Patch Product Portfolio
- 4.4.5 Johnson & Johnson Recent Developments
- 4.5 Novartis
- 4.5.1 Novartis Company Information
- 4.5.2 Novartis Business Overview
- 4.5.3 Novartis Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Novartis Skin Patch Product Portfolio
- 4.5.5 Novartis Recent Developments
- 4.6 Mylan
- 4.6.1 Mylan Company Information
- 4.6.2 Mylan Business Overview
- 4.6.3 Mylan Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mylan Skin Patch Product Portfolio
- 4.6.5 Mylan Recent Developments
- 4.7 Lingrui
- 4.7.1 Lingrui Company Information
- 4.7.2 Lingrui Business Overview
- 4.7.3 Lingrui Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Lingrui Skin Patch Product Portfolio
- 4.7.5 Lingrui Recent Developments
- 4.8 Bayer
- 4.8.1 Bayer Company Information
- 4.8.2 Bayer Business Overview
- 4.8.3 Bayer Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bayer Skin Patch Product Portfolio
- 4.8.5 Bayer Recent Developments
- 4.9 Teikoku Seiyaku
- 4.9.1 Teikoku Seiyaku Company Information
- 4.9.2 Teikoku Seiyaku Business Overview
- 4.9.3 Teikoku Seiyaku Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Teikoku Seiyaku Skin Patch Product Portfolio
- 4.9.5 Teikoku Seiyaku Recent Developments
- 4.10 Purdue Pharma
- 4.10.1 Purdue Pharma Company Information
- 4.10.2 Purdue Pharma Business Overview
- 4.10.3 Purdue Pharma Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Purdue Pharma Skin Patch Product Portfolio
- 4.10.5 Purdue Pharma Recent Developments
- 4.11 Mundipharma International
- 4.11.1 Mundipharma International Company Information
- 4.11.2 Mundipharma International Business Overview
- 4.11.3 Mundipharma International Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Mundipharma International Skin Patch Product Portfolio
- 4.11.5 Mundipharma International Recent Developments
- 4.12 Luye Pharma Group
- 4.12.1 Luye Pharma Group Company Information
- 4.12.2 Luye Pharma Group Business Overview
- 4.12.3 Luye Pharma Group Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Luye Pharma Group Skin Patch Product Portfolio
- 4.12.5 Luye Pharma Group Recent Developments
- 4.13 Hisamitsu Pharmaceutical
- 4.13.1 Hisamitsu Pharmaceutical Company Information
- 4.13.2 Hisamitsu Pharmaceutical Business Overview
- 4.13.3 Hisamitsu Pharmaceutical Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Hisamitsu Pharmaceutical Skin Patch Product Portfolio
- 4.13.5 Hisamitsu Pharmaceutical Recent Developments
5 Global Skin Patch Market Scenario by Region
- 5.1 Global Skin Patch Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Skin Patch Sales by Region: 2021-2032
- 5.2.1 Global Skin Patch Sales by Region: 2021-2026
- 5.2.2 Global Skin Patch Sales by Region: 2027-2032
- 5.3 Global Skin Patch Revenue by Region: 2021-2032
- 5.3.1 Global Skin Patch Revenue by Region: 2021-2026
- 5.3.2 Global Skin Patch Revenue by Region: 2027-2032
- 5.4 North America Skin Patch Market Facts & Figures by Country
- 5.4.1 North America Skin Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Skin Patch Sales by Country (2021-2032)
- 5.4.3 North America Skin Patch Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Skin Patch Market Facts & Figures by Country
- 5.5.1 Europe Skin Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Skin Patch Sales by Country (2021-2032)
- 5.5.3 Europe Skin Patch Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Skin Patch Market Facts & Figures by Country
- 5.6.1 Asia Pacific Skin Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Skin Patch Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Skin Patch Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Skin Patch Market Facts & Figures by Country
- 5.7.1 South America Skin Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Skin Patch Sales by Country (2021-2032)
- 5.7.3 South America Skin Patch Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Skin Patch Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Skin Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Skin Patch Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Skin Patch Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Skin Patch Sales by Type (2021-2032)
- 6.1.1 Global Skin Patch Sales by Type (2021-2032) & (k pcs)
- 6.1.2 Global Skin Patch Sales Market Share by Type (2021-2032)
- 6.2 Global Skin Patch Revenue by Type (2021-2032)
- 6.2.1 Global Skin Patch Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Skin Patch Revenue Market Share by Type (2021-2032)
- 6.3 Global Skin Patch Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Skin Patch Sales by Application (2021-2032)
- 7.1.1 Global Skin Patch Sales by Application (2021-2032) & (k pcs)
- 7.1.2 Global Skin Patch Sales Market Share by Application (2021-2032)
- 7.2 Global Skin Patch Revenue by Application (2021-2032)
- 7.2.1 Global Skin Patch Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Skin Patch Revenue Market Share by Application (2021-2032)
- 7.3 Global Skin Patch Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Skin Patch Value Chain Analysis
- 8.1.1 Skin Patch Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Skin Patch Production Mode & Process
- 8.2 Skin Patch Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Skin Patch Distributors
- 8.2.3 Skin Patch Customers
9 Global Skin Patch Analyzing Market Dynamics
- 9.1 Skin Patch Industry Trends
- 9.2 Skin Patch Industry Drivers
- 9.3 Skin Patch Industry Opportunities and Challenges
- 9.4 Skin Patch Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst